| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.72 | 0.006 | 0.72 | 5 Hydroxytryptamine release stimulant | 0.69 0.008 CID_53481645 | ||
| 0.668 | 0.003 | 0.668 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.338 0.165 CID_53481645 | ||
| 0.632 | 0.005 | 0.632 | GABA C receptor rho-3 antagonist | |||
| 0.593 | 0.02 | 0.593 | Aldehyde oxidase inhibitor | |||
| 0.583 | 0.013 | 0.583 | 5 Hydroxytryptamine release inhibitor | 0.47 0.043 CID_53481645 | ||
| 0.571 | 0.005 | 0.571 | Peroxidase inhibitor | |||
| 0.574 | 0.009 | 0.574 | Calcium channel L-type activator | 0.406 0.077 CID_53481645 | ||
| 0.558 | 0.003 | 0.558 | GABA C receptor agonist | |||
| 0.55 | 0.016 | 0.564 | Histamine release inhibitor | 0.564 0.014 CID_53481645 | CID_53481645 | |
| 0.492 | 0.025 | 0.492 | Aryl hydrocarbon receptor agonist | 0.196 0.104 CID_53481645 | ||
| 0.45 | 0.007 | 0.45 | Alpha-N-acetylglucosaminidase inhibitor | 0.409 0.008 CID_53481645 | ||
| 0.429 | 0.004 | 0.429 | Porphobilinogen synthase inhibitor | |||
| 0.452 | 0.04 | 0.612 | Vasodilator, peripheral | 0.612 0.015 CID_53481645 | CID_53481645 | |
| 0.422 | 0.018 | 0.422 | Calcium channel activator | 0.235 0.165 CID_53481645 | ||
| 0.41 | 0.025 | 0.41 | Superoxide dismutase inhibitor | |||
| 0.41 | 0.029 | 0.41 | Interleukin antagonist | 0.239 0.066 CID_53481645 | ||
| 0.383 | 0.004 | 0.383 | GABA C receptor rho-2 antagonist | 0.127 0.111 CID_53481645 | ||
| 0.397 | 0.023 | 0.397 | Insulysin inhibitor | |||
| 0.378 | 0.004 | 0.388 | Triose-phosphate isomerase inhibitor | 0.388 0.004 CID_53481645 | CID_53481645 | |
| 0.371 | 0.004 | 0.371 | Ferrochelatase inhibitor | |||
| 0.37 | 0.003 | 0.37 | Phenylalanine 4-hydroxylase inhibitor | 0.061 0.057 CID_53481645 | ||
| 0.446 | 0.085 | 0.597 | Caspase 9 stimulant | 0.597 0.036 CID_53481645 | CID_53481645 | |
| 0.354 | 0.004 | 0.354 | Alcohol oxidase inhibitor | |||
| 0.352 | 0.003 | 0.352 | GABA C receptor rho-1 antagonist | |||
| 0.373 | 0.026 | 0.502 | DNA synthesis inhibitor | 0.502 0.013 CID_53481645 | CID_53481645 | |
| 0.347 | 0.014 | 0.347 | Lipocortins synthesis antagonist | 0.229 0.041 CID_53481645 | ||
| 0.337 | 0.004 | 0.337 | GABA C receptor antagonist | |||
| 0.337 | 0.005 | 0.337 | Adenylate kinase inhibitor | 0.215 0.013 CID_53481645 | ||
| 0.34 | 0.013 | 0.34 | Gastrin inhibitor | 0.248 0.081 CID_53481645 | ||
| 0.343 | 0.028 | 0.343 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.335 | 0.02 | 0.335 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.311 | 0.023 | 0.316 | DNA methyltransferase I inhibitor | 0.316 0.021 CID_53481645 | CID_53481645 | |
| 0.291 | 0.005 | 0.653 | AMP-activated protein kinase stimulant | 0.653 0.002 CID_53481645 | CID_53481645 | |
| 0.298 | 0.012 | 0.298 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.326 | 0.041 | 0.326 | Pyruvate kinase inhibitor | |||
| 0.286 | 0.007 | 0.286 | Histidine decarboxylase inhibitor | |||
| 0.304 | 0.027 | 0.375 | DNA methylase inhibitor | 0.375 0.013 CID_53481645 | CID_53481645 | |
| 0.304 | 0.027 | 0.304 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.338 | 0.062 | 0.614 | Apoptosis antagonist | 0.614 0.008 CID_53481645 | CID_53481645 | |
| 0.281 | 0.007 | 0.281 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.283 | 0.011 | 0.399 | UDP-glucose 4-epimerase inhibitor | 0.399 0.006 CID_53481645 | CID_53481645 | |
| 0.277 | 0.008 | 0.277 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.247 0.01 CID_53481645 | ||
| 0.308 | 0.044 | 0.403 | Interleukin agonist | 0.403 0.018 CID_53481645 | CID_53481645 | |
| 0.357 | 0.098 | 0.622 | Antibacterial | 0.622 0.016 CID_53481645 | CID_53481645 | |
| 0.312 | 0.056 | 0.312 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.258 | 0.003 | 0.258 | GABA B receptor agonist | 0.07 0.068 CID_53481645 | ||
| 0.271 | 0.016 | 0.271 | Succinate dehydrogenase inhibitor | |||
| 0.327 | 0.075 | 0.613 | Cholesterol antagonist | 0.613 0.017 CID_53481645 | CID_53481645 | |
| 0.257 | 0.006 | 0.257 | Protein kinase C gamma inhibitor | 0.22 0.01 CID_53481645 | ||
| 0.251 | 0.006 | 0.251 | CF transmembrane conductance regulator agonist | 0.249 0.006 CID_53481645 | ||
| 0.279 | 0.037 | 0.279 | RNA-directed DNA polymerase inhibitor | 0.22 0.074 CID_53481645 | ||
| 0.247 | 0.005 | 0.247 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.335 | 0.108 | 0.335 | 15-Lipoxygenase inhibitor | |||
| 0.234 | 0.009 | 0.755 | Beta glucuronidase inhibitor | 0.755 0.002 CID_53481645 | CID_53481645 | |
| 0.252 | 0.031 | 0.253 | Nitric-oxide synthase stimulant | 0.253 0.031 CID_53481645 | CID_53481645 | |
| 0.299 | 0.08 | 0.299 | Sodium/bile acid cotransporter inhibitor | |||
| 0.224 | 0.01 | 0.224 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.265 | 0.053 | 0.265 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.217 | 0.005 | 0.217 | DOPA decarboxylase inhibitor | |||
| 0.217 | 0.006 | 0.217 | Prolactin inhibitor | |||
| 0.215 | 0.013 | 0.215 | Catalase inhibitor | |||
| 0.26 | 0.059 | 0.335 | Cyclic AMP phosphodiesterase inhibitor | 0.335 0.03 CID_53481645 | CID_53481645 | |
| 0.205 | 0.005 | 0.205 | Myeloperoxidase inhibitor | |||
| 0.22 | 0.023 | 0.22 | Aldehyde dehydrogenase inhibitor | 0.121 0.07 CID_53481645 | ||
| 0.21 | 0.015 | 0.21 | Falcipain 3 inhibitor | |||
| 0.236 | 0.045 | 0.236 | I kappa B kinase epsilon inhibitor | |||
| 0.194 | 0.006 | 0.194 | Histamine N-methyltransferase inhibitor | |||
| 0.198 | 0.011 | 0.198 | Creatine kinase inhibitor | |||
| 0.188 | 0.005 | 0.188 | Ca2+-transporting ATPase inhibitor | 0.17 0.013 CID_53481645 | ||
| 0.188 | 0.006 | 0.188 | Biliverdin reductase inhibitor | 0.052 0.049 CID_53481645 | ||
| 0.211 | 0.03 | 0.211 | Neurotensin receptor agonist | |||
| 0.284 | 0.104 | 0.693 | Transcription factor NF kappa B inhibitor | 0.693 0.021 CID_53481645 | CID_53481645 | |
| 0.323 | 0.144 | 0.727 | Cyclophilin D inhibitor | 0.727 0.012 CID_53481645 | CID_53481645 | |
| 0.281 | 0.102 | 0.665 | Antithrombotic | 0.665 0.01 CID_53481645 | CID_53481645 | |
| 0.195 | 0.017 | 0.195 | 5 Hydroxytryptamine 3A agonist | |||
| 0.191 | 0.013 | 0.191 | Alcohol dehydrogenase inhibitor | 0.085 0.072 CID_53481645 | ||
| 0.181 | 0.004 | 0.181 | Aconitate hydratase inhibitor | |||
| 0.187 | 0.01 | 0.187 | Keratolytic | |||
| 0.236 | 0.061 | 0.236 | MAP kinase kinase 2 inhibitor | |||
| 0.212 | 0.037 | 0.212 | Phospholipase A2 inhibitor | 0.137 0.09 CID_53481645 | ||
| 0.236 | 0.064 | 0.269 | Psychostimulant | 0.269 0.052 CID_53481645 | CID_53481645 | |
| 0.18 | 0.012 | 0.18 | Heat shock protein 70 antagonist | 0.149 0.048 CID_53481645 | ||
| 0.186 | 0.019 | 0.186 | Carbonic anhydrase III inhibitor | |||
| 0.223 | 0.056 | 0.223 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.177 | 0.012 | 0.177 | Electrolyte absorption antagonist | |||
| 0.173 | 0.009 | 0.173 | Argininosuccinate synthase inhibitor | 0.054 0.042 CID_53481645 | ||
| 0.191 | 0.028 | 0.191 | Toll-Like receptor 2 antagonist | 0.103 0.099 CID_53481645 | ||
| 0.187 | 0.025 | 0.187 | Aminopeptidase B inhibitor | |||
| 0.194 | 0.032 | 0.321 | Cell wall synthesis inhibitor | 0.321 0.009 CID_53481645 | CID_53481645 | |
| 0.179 | 0.018 | 0.227 | Photosensitizer | 0.227 0.008 CID_53481645 | CID_53481645 | |
| 0.183 | 0.023 | 0.248 | Xanthine oxidase inhibitor | 0.248 0.012 CID_53481645 | CID_53481645 | |
| 0.18 | 0.022 | 0.18 | Carbonic anhydrase XV inhibitor | |||
| 0.17 | 0.014 | 0.289 | NADH dehydrogenase inhibitor | 0.289 0.007 CID_53481645 | CID_53481645 | |
| 0.22 | 0.064 | 0.22 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.194 | 0.039 | 0.194 | Hexokinase inhibitor | 0.194 0.038 CID_53481645 | ||
| 0.183 | 0.029 | 0.183 | Cystathionine beta-synthase inhibitor | |||
| 0.177 | 0.027 | 0.177 | MAP kinase kinase 4 inhibitor | |||
| 0.177 | 0.029 | 0.177 | MAP3K9 inhibitor | |||
| 0.186 | 0.039 | 0.186 | NADPH oxidase inhibitor | |||
| 0.157 | 0.012 | 0.157 | Somatostatin 1 agonist | 0.083 0.048 CID_53481645 | ||
| 0.164 | 0.023 | 0.164 | TRPA1 agonist | |||
| 0.149 | 0.008 | 0.2 | Glycine receptor antagonist | 0.2 0.004 CID_53481645 | CID_53481645 | |
| 0.21 | 0.07 | 0.21 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.239 | 0.101 | 0.558 | Immunostimulant | 0.558 0.022 CID_53481645 | CID_53481645 | |
| 0.196 | 0.058 | 0.196 | Mcl-1 antagonist | |||
| 0.155 | 0.019 | 0.155 | Protein kinase C delta inhibitor | 0.13 0.031 CID_53481645 | ||
| 0.149 | 0.013 | 0.149 | Glutamate decarboxylase inhibitor | |||
| 0.15 | 0.014 | 0.15 | 5 Hydroxytryptamine 1 agonist | |||
| 0.204 | 0.069 | 0.204 | Insulin sensitizer | |||
| 0.163 | 0.03 | 0.163 | GABA receptor agonist | |||
| 0.192 | 0.059 | 0.192 | Dual specificity phosphatase inhibitor | |||
| 0.215 | 0.084 | 0.215 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.167 | 0.035 | 0.167 | Adenylate cyclase inhibitor | 0.127 0.061 CID_53481645 | ||
| 0.15 | 0.02 | 0.15 | Protein kinase C zeta inhibitor | 0.106 0.044 CID_53481645 | ||
| 0.156 | 0.026 | 0.345 | Mediator release inhibitor | 0.345 0.005 CID_53481645 | CID_53481645 | |
| 0.159 | 0.029 | 0.159 | Interleukin 8 antagonist | |||
| 0.152 | 0.022 | 0.152 | Uric acid excretion stimulant | 0.135 0.029 CID_53481645 | ||
| 0.145 | 0.017 | 0.145 | Glutamate dehydrogenase inhibitor | |||
| 0.167 | 0.039 | 0.167 | Adenylate cyclase stimulant | 0.157 0.051 CID_53481645 | ||
| 0.15 | 0.023 | 0.15 | Urease inhibitor | |||
| 0.132 | 0.004 | 0.132 | GABA B receptor antagonist | |||
| 0.192 | 0.067 | 0.192 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.183 | 0.058 | 0.183 | Phospholipase C inhibitor | |||
| 0.2 | 0.075 | 0.2 | Death-associated protein kinase 3 inhibitor | |||
| 0.129 | 0.006 | 0.129 | Cholecystokinin antagonist | |||
| 0.214 | 0.091 | 0.214 | Dyrk kinase inhibitor | |||
| 0.133 | 0.01 | 0.133 | NMDA receptor agonist | |||
| 0.163 | 0.042 | 0.163 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.17 | 0.049 | 0.17 | Mannose-6-phosphate isomerase inhibitor | 0.163 0.054 CID_53481645 | ||
| 0.158 | 0.037 | 0.158 | Protein kinase (CK2) alpha inhibitor | |||
| 0.196 | 0.076 | 0.196 | Histone acetyltransferase inhibitor | |||
| 0.178 | 0.06 | 0.178 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.127 | 0.01 | 0.127 | Xanthine dehydrogenase inhibitor | 0.057 0.04 CID_53481645 | ||
| 0.149 | 0.033 | 0.149 | Protein kinase (CK2) inhibitor | |||
| 0.157 | 0.041 | 0.157 | Cathepsin H inhibitor | |||
| 0.125 | 0.011 | 0.125 | D-Ala-D-Ala ligase inhibitor | |||
| 0.174 | 0.06 | 0.174 | Catenin beta inhibitor | |||
| 0.17 | 0.057 | 0.235 | Interferon gamma antagonist | 0.235 0.031 CID_53481645 | CID_53481645 | |
| 0.172 | 0.061 | 0.193 | Protein-tyrosine phosphatase inhibitor | 0.193 0.05 CID_53481645 | CID_53481645 | |
| 0.135 | 0.024 | 0.135 | Carbonic anhydrase VI inhibitor | |||
| 0.122 | 0.012 | 0.167 | Protein kinase C eta inhibitor | 0.167 0.006 CID_53481645 | CID_53481645 | |
| 0.116 | 0.006 | 0.116 | Kainate receptor antagonist | |||
| 0.118 | 0.009 | 0.118 | NMDA receptor glycine site agonist | |||
| 0.13 | 0.023 | 0.175 | Phosphofructokinase-1 inhibitor | 0.175 0.014 CID_53481645 | CID_53481645 | |
| 0.165 | 0.058 | 0.165 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.113 | 0.009 | 0.116 | Protein kinase C beta inhibitor | 0.116 0.008 CID_53481645 | CID_53481645 | |
| 0.179 | 0.074 | 0.179 | LIM domain kinase 1 inhibitor | |||
| 0.12 | 0.016 | 0.12 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.111 | 0.007 | 0.111 | Cholecystokinin A antagonist | |||
| 0.243 | 0.141 | 0.414 | Vasodilator, coronary | 0.414 0.031 CID_53481645 | CID_53481645 | |
| 0.219 | 0.117 | 0.219 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.132 | 0.03 | 0.132 | NMDA receptor antagonist | |||
| 0.135 | 0.033 | 0.135 | Potassium channel (Ca-activated) activator | |||
| 0.171 | 0.072 | 0.171 | Growth hormone agonist | |||
| 0.208 | 0.109 | 0.32 | DNA damaging | 0.32 0.05 CID_53481645 | CID_53481645 | |
| 0.161 | 0.063 | 0.332 | NOS3 expression enhancer | 0.332 0.014 CID_53481645 | CID_53481645 | |
| 0.147 | 0.049 | 0.147 | Antibacterial (Helicobacter pylori) | |||
| 0.106 | 0.011 | 0.106 | AMPA receptor antagonist | |||
| 0.1 | 0.005 | 0.1 | Kainate receptor 2 antagonist | |||
| 0.099 | 0.007 | 0.099 | 5 Hydroxytryptamine 1B agonist | |||
| 0.133 | 0.042 | 0.133 | Nav1.4 sodium channel blocker | |||
| 0.117 | 0.026 | 0.117 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.163 | 0.072 | 0.331 | Thrombolytic | 0.331 0.019 CID_53481645 | CID_53481645 | |
| 0.179 | 0.089 | 0.179 | Focal adhesion kinase 2 inhibitor | |||
| 0.189 | 0.099 | 0.189 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.165 | 0.076 | 0.165 | Sigma receptor agonist | |||
| 0.158 | 0.07 | 0.158 | Cytidine deaminase inhibitor | |||
| 0.165 | 0.078 | 0.252 | ATPase inhibitor | 0.252 0.013 CID_53481645 | CID_53481645 | |
| 0.095 | 0.009 | 0.095 | MDM2 inhibitor | |||
| 0.104 | 0.019 | 0.104 | Glycine receptor agonist | 0.072 0.051 CID_53481645 | ||
| 0.092 | 0.007 | 0.092 | Somatostatin 5 antagonist | 0.037 0.019 CID_53481645 | ||
| 0.148 | 0.065 | 0.393 | Amylase inhibitor | 0.393 0.01 CID_53481645 | CID_53481645 | |
| 0.16 | 0.077 | 0.16 | Arachidonic acid antagonist | |||
| 0.228 | 0.145 | 0.48 | Interleukin 2 agonist | 0.48 0.011 CID_53481645 | CID_53481645 | |
| 0.112 | 0.029 | 0.112 | Bile acid receptor antagonist | |||
| 0.1 | 0.017 | 0.1 | Purinergic P2X1 antagonist | |||
| 0.095 | 0.013 | 0.095 | Glutamate (mGluR6) antagonist | |||
| 0.089 | 0.006 | 0.089 | AMPA 1 receptor antagonist | |||
| 0.149 | 0.067 | 0.149 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.184 | 0.103 | 0.777 | Angiogenesis stimulant | 0.777 0.004 CID_53481645 | CID_53481645 | |
| 0.106 | 0.025 | 0.106 | Aminopeptidase I inhibitor | |||
| 0.096 | 0.016 | 0.096 | MAP kinase kinase 7 inhibitor | |||
| 0.093 | 0.014 | 0.093 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.085 | 0.006 | 0.085 | AMPA 4 receptor antagonist | |||
| 0.09 | 0.012 | 0.09 | NMDA receptor subunit 3B antagonist | |||
| 0.102 | 0.025 | 0.102 | GABA aminotransferase inhibitor | 0.072 0.059 CID_53481645 | ||
| 0.12 | 0.043 | 0.12 | Gastric antisecretory | |||
| 0.1 | 0.024 | 0.1 | CDC7 inhibitor | |||
| 0.109 | 0.033 | 0.109 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.136 | 0.061 | 0.231 | Cyclooxygenase 3 inhibitor | 0.231 0.011 CID_53481645 | CID_53481645 | |
| 0.091 | 0.016 | 0.126 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.126 0.01 CID_53481645 | CID_53481645 | |
| 0.176 | 0.102 | 0.176 | Neurotrophic factor enhancer | 0.168 0.112 CID_53481645 | ||
| 0.16 | 0.085 | 0.16 | Death-associated protein kinase 2 inhibitor | |||
| 0.08 | 0.006 | 0.08 | Nicotinic acid receptor agonist | |||
| 0.152 | 0.079 | 0.233 | Melanin inhibitor | 0.233 0.031 CID_53481645 | CID_53481645 | |
| 0.211 | 0.139 | 0.26 | Hypoxia-inducible factor 1 alpha inhibitor | 0.26 0.092 CID_53481645 | CID_53481645 | |
| 0.088 | 0.017 | 0.088 | NMDA 2A receptor antagonist | |||
| 0.08 | 0.009 | 0.08 | Dihydroorotase inhibitor | |||
| 0.079 | 0.008 | 0.079 | Glutamate (mGluR4) antagonist | |||
| 0.112 | 0.041 | 0.112 | Antineoplastic alkaloid | |||
| 0.091 | 0.02 | 0.091 | CDC25B inhibitor | |||
| 0.11 | 0.04 | 0.11 | Interleukin 12 antagonist | 0.109 0.041 CID_53481645 | ||
| 0.104 | 0.034 | 0.104 | Adrenaline agonist | |||
| 0.079 | 0.009 | 0.079 | Glutamate (mGluR1a) antagonist | |||
| 0.078 | 0.009 | 0.078 | TRPM8 blocker | |||
| 0.091 | 0.021 | 0.091 | Phospholipase D inhibitor | |||
| 0.135 | 0.066 | 0.135 | M17 leucyl aminopeptidase inhibitor | |||
| 0.073 | 0.004 | 0.073 | Kainate receptor 1 antagonist | |||
| 0.089 | 0.021 | 0.089 | Bombesin 1 receptor agonist | |||
| 0.102 | 0.035 | 0.102 | CYP2A6 inhibitor | |||
| 0.084 | 0.016 | 0.084 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.087 | 0.02 | 0.087 | Glutamate (mGluR7) antagonist | |||
| 0.253 | 0.186 | 0.708 | Alpha-glucosidase inhibitor | 0.708 0.032 CID_53481645 | CID_53481645 | |
| 0.078 | 0.012 | 0.078 | NMDA receptor subunit 3A antagonist | |||
| 0.075 | 0.009 | 0.075 | Nicotinic acid receptor 2 agonist | |||
| 0.086 | 0.02 | 0.086 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.087 | 0.022 | 0.087 | 5 Hydroxytryptamine 3 agonist | |||
| 0.142 | 0.078 | 0.347 | Hemostatic | 0.347 0.012 CID_53481645 | CID_53481645 | |
| 0.084 | 0.02 | 0.084 | GABA receptor antagonist | |||
| 0.07 | 0.007 | 0.07 | Cholecystokinin B antagonist | |||
| 0.077 | 0.014 | 0.077 | Topoisomerase II beta inhibitor | |||
| 0.103 | 0.041 | 0.103 | Ornithine decarboxylase inhibitor | |||
| 0.083 | 0.021 | 0.083 | Beta 3 adrenoreceptor antagonist | |||
| 0.072 | 0.011 | 0.072 | Somatostatin 1 antagonist | 0.049 0.021 CID_53481645 | ||
| 0.067 | 0.005 | 0.067 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.123 | 0.061 | 0.187 | Protein-tyrosine phosphatase 1B inhibitor | 0.187 0.033 CID_53481645 | CID_53481645 | |
| 0.098 | 0.036 | 0.098 | Macrophage migration inhibitory factor inhibitor | |||
| 0.177 | 0.116 | 0.177 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.074 | 0.012 | 0.075 | Adenine nucleotide translocase inhibitor | 0.075 0.012 CID_53481645 | CID_53481645 | |
| 0.144 | 0.082 | 0.144 | Diuretic | 0.114 0.113 CID_53481645 | ||
| 0.075 | 0.015 | 0.075 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.068 | 0.008 | 0.068 | Farnesoid X receptor agonist | |||
| 0.077 | 0.018 | 0.077 | Bombesin 2 receptor antagonist | |||
| 0.078 | 0.019 | 0.078 | Cyclin D1 inhibitor | |||
| 0.13 | 0.072 | 0.144 | CC chemokine 6 receptor antagonist | 0.144 0.031 CID_53481645 | CID_53481645 | |
| 0.083 | 0.025 | 0.083 | Prostaglandin EP2 antagonist | |||
| 0.079 | 0.022 | 0.079 | GABA A receptor antagonist | |||
| 0.087 | 0.031 | 0.087 | Neuronal nicotinic receptor antagonist | |||
| 0.072 | 0.016 | 0.072 | Dihydroorotate oxidase inhibitor | |||
| 0.081 | 0.025 | 0.081 | NMDA 2C receptor antagonist | |||
| 0.133 | 0.077 | 0.133 | Neurotrophic factor | |||
| 0.073 | 0.018 | 0.073 | Prolactin release inhibitor | |||
| 0.122 | 0.068 | 0.122 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.075 | 0.021 | 0.075 | Prostaglandin E2 antagonist | |||
| 0.065 | 0.011 | 0.065 | Glutamate (mGluR group III) antagonist | |||
| 0.062 | 0.009 | 0.062 | Retinoic acid alpha receptor agonist | |||
| 0.102 | 0.049 | 0.15 | Phosphodiesterase 6D inhibitor | 0.15 0.01 CID_53481645 | CID_53481645 | |
| 0.095 | 0.042 | 0.095 | Hematopoietic | |||
| 0.095 | 0.043 | 0.095 | Acetylcholine nicotinic antagonist | |||
| 0.057 | 0.006 | 0.057 | NMDA 2D receptor antagonist | |||
| 0.086 | 0.035 | 0.086 | Benzodiazepine agonist | |||
| 0.066 | 0.015 | 0.066 | Immunoglobulin Fc receptor antagonist | |||
| 0.133 | 0.083 | 0.133 | CDC-like kinase 1 inhibitor | |||
| 0.074 | 0.024 | 0.074 | Ornithine carbamoyltransferase inhibitor | |||
| 0.071 | 0.02 | 0.164 | Phosphorylase inhibitor | 0.164 0.006 CID_53481645 | CID_53481645 | |
| 0.148 | 0.098 | 0.148 | Dual specificity phosphatase 3 inhibitor | |||
| 0.182 | 0.132 | 0.182 | Calpain inhibitor | |||
| 0.06 | 0.01 | 0.06 | RNA-directed RNA polymerase inhibitor | |||
| 0.149 | 0.099 | 0.149 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.057 | 0.007 | 0.057 | AMPA 3 receptor antagonist | |||
| 0.065 | 0.016 | 0.065 | Aldosterone antagonist | |||
| 0.171 | 0.122 | 0.371 | Antiamyloidogenic | 0.371 0.034 CID_53481645 | CID_53481645 | |
| 0.08 | 0.031 | 0.08 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.115 | 0.067 | 0.115 | Caspase 3 inhibitor | |||
| 0.125 | 0.078 | 0.144 | Interleukin 4 antagonist | 0.144 0.056 CID_53481645 | CID_53481645 | |
| 0.055 | 0.007 | 0.055 | Free fatty acid receptor 1 antagonist | |||
| 0.097 | 0.049 | 0.097 | Pim-3 kinase inhibitor | |||
| 0.066 | 0.019 | 0.066 | Pregnane X receptor antagonist | |||
| 0.103 | 0.055 | 0.103 | Pim-1 kinase inhibitor | |||
| 0.087 | 0.039 | 0.087 | NMDA 2 receptor antagonist | |||
| 0.092 | 0.045 | 0.092 | GABA A receptor agonist | |||
| 0.096 | 0.05 | 0.096 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.055 | 0.009 | 0.055 | Glutamate (mGluR8) agonist | |||
| 0.07 | 0.024 | 0.07 | Bombesin 3 receptor antagonist | |||
| 0.052 | 0.007 | 0.052 | Uridine phosphorylase inhibitor | 0.044 0.01 CID_53481645 | ||
| 0.065 | 0.02 | 0.065 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.08 | 0.036 | 0.08 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.065 | 0.021 | 0.065 | Thromboxane synthase inhibitor | |||
| 0.095 | 0.051 | 0.095 | Androgen antagonist | |||
| 0.053 | 0.01 | 0.053 | Integrin alpha2 antagonist | |||
| 0.054 | 0.011 | 0.054 | Bombesin 1 receptor antagonist | |||
| 0.056 | 0.013 | 0.056 | Cholecystokinin B agonist | |||
| 0.05 | 0.007 | 0.05 | Purinergic P2Y14 antagonist | |||
| 0.095 | 0.052 | 0.118 | Glutamate release inhibitor | 0.118 0.023 CID_53481645 | CID_53481645 | |
| 0.066 | 0.023 | 0.066 | 5 Hydroxytryptamine 7 agonist | |||
| 0.187 | 0.145 | 0.187 | Neuropeptide Y2 antagonist | |||
| 0.074 | 0.032 | 0.074 | Aryl hydrocarbon receptor antagonist | |||
| 0.05 | 0.008 | 0.05 | Melatonin receptor 1A agonist | |||
| 0.078 | 0.037 | 0.078 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.082 | 0.041 | 0.082 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.063 | 0.022 | 0.063 | Plasminogen activator inhibitor antagonist | |||
| 0.052 | 0.011 | 0.052 | Kainate receptor agonist | |||
| 0.061 | 0.02 | 0.061 | CD45 antagonist | |||
| 0.054 | 0.014 | 0.054 | Nerve growth factor antagonist | |||
| 0.152 | 0.112 | 0.189 | Anesthetic general | 0.189 0.08 CID_53481645 | CID_53481645 | |
| 0.053 | 0.013 | 0.053 | GABA uptake inhibitor | |||
| 0.061 | 0.021 | 0.114 | Heparanase inhibitor | 0.114 0.003 CID_53481645 | CID_53481645 | |
| 0.044 | 0.005 | 0.044 | Bombesin agonist | |||
| 0.045 | 0.006 | 0.045 | Kainate receptor 5 antagonist | |||
| 0.053 | 0.014 | 0.053 | Somatostatin 2 antagonist | 0.024 0.022 CID_53481645 | ||
| 0.051 | 0.013 | 0.051 | Fumarate hydratase inhibitor | |||
| 0.085 | 0.048 | 0.085 | CC chemokine 5 receptor agonist | |||
| 0.042 | 0.005 | 0.042 | Nicotinic acid receptor 2 antagonist | |||
| 0.131 | 0.094 | 0.131 | Thiol protease inhibitor | |||
| 0.107 | 0.071 | 0.245 | Monophenol monooxygenase inhibitor | 0.245 0.025 CID_53481645 | CID_53481645 | |
| 0.071 | 0.034 | 0.071 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.069 | 0.033 | 0.069 | Prostaglandin F2 alpha antagonist | |||
| 0.05 | 0.013 | 0.05 | Somatostatin agonist | |||
| 0.054 | 0.018 | 0.054 | Geranyltranstransferase inhibitor | |||
| 0.058 | 0.022 | 0.058 | Adenosine deaminase inhibitor | 0.044 0.037 CID_53481645 | ||
| 0.043 | 0.007 | 0.043 | NMDA receptor glycine site antagonist | |||
| 0.047 | 0.011 | 0.047 | HCV NS5B polymerase inhibitor | |||
| 0.063 | 0.027 | 0.063 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.106 | 0.07 | 0.121 | Mucolytic | 0.121 0.054 CID_53481645 | CID_53481645 | |
| 0.188 | 0.153 | 0.188 | Lipoxygenase inhibitor | |||
| 0.086 | 0.05 | 0.086 | Acetylcholine nicotinic agonist | |||
| 0.071 | 0.036 | 0.071 | 5 Hydroxytryptamine 2A agonist | |||
| 0.056 | 0.022 | 0.056 | Bombesin antagonist | |||
| 0.053 | 0.019 | 0.053 | Nicotinic acid receptor 1 agonist | |||
| 0.063 | 0.03 | 0.063 | Ryanodine receptor antagonist | |||
| 0.041 | 0.008 | 0.042 | Protein kinase C beta I inhibitor | 0.042 0.007 CID_53481645 | CID_53481645 | |
| 0.05 | 0.018 | 0.05 | Angiotensin AT1 receptor antagonist | |||
| 0.106 | 0.074 | 0.117 | Acetylcholine release stimulant | 0.117 0.052 CID_53481645 | CID_53481645 | |
| 0.064 | 0.032 | 0.064 | Carbonic anhydrase VB inhibitor | |||
| 0.042 | 0.011 | 0.042 | Protein kinase (CK2) beta inhibitor | |||
| 0.036 | 0.005 | 0.036 | Bombesin 3 receptor agonist | |||
| 0.055 | 0.024 | 0.055 | Factor III inhibitor | |||
| 0.04 | 0.009 | 0.04 | Kainate receptor 4 antagonist | |||
| 0.051 | 0.021 | 0.051 | Growth hormone release inhibitor | |||
| 0.065 | 0.034 | 0.065 | Glutamate (mGluR1) antagonist | |||
| 0.046 | 0.015 | 0.046 | Glutamate (mGluR3) antagonist | |||
| 0.065 | 0.035 | 0.065 | Carbonic anhydrase stimulant | |||
| 0.157 | 0.127 | 0.157 | Growth factor agonist | |||
| 0.05 | 0.021 | 0.05 | Guanylate cyclase inhibitor | |||
| 0.047 | 0.017 | 0.047 | Somatostatin 4 agonist | |||
| 0.185 | 0.156 | 0.185 | Transcription factor STAT3 inhibitor | |||
| 0.056 | 0.027 | 0.056 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.043 | 0.013 | 0.043 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.053 | 0.024 | 0.053 | Thymidylate synthase inhibitor | |||
| 0.043 | 0.013 | 0.043 | Carnitine palmitoyltransferase inhibitor | |||
| 0.08 | 0.052 | 0.125 | Interferon agonist | 0.125 0.015 CID_53481645 | CID_53481645 | |
| 0.172 | 0.145 | 0.172 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.051 | 0.023 | 0.06 | Neuraminidase (Influenza A) inhibitor | 0.06 0.013 CID_53481645 | CID_53481645 | |
| 0.065 | 0.038 | 0.084 | Neuraminidase inhibitor | 0.084 0.023 CID_53481645 | CID_53481645 | |
| 0.107 | 0.079 | 0.198 | Microtubule formation inhibitor | 0.198 0.02 CID_53481645 | CID_53481645 | |
| 0.041 | 0.014 | 0.041 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.067 | 0.04 | 0.104 | Interferon inducer | 0.104 0.011 CID_53481645 | CID_53481645 | |
| 0.16 | 0.134 | 0.572 | Free radical scavenger | 0.572 0.01 CID_53481645 | CID_53481645 | |
| 0.061 | 0.035 | 0.061 | Protein kinase C theta inhibitor | |||
| 0.044 | 0.018 | 0.044 | Retinoid X receptor antagonist | |||
| 0.049 | 0.024 | 0.049 | Glutamate (mGluR group III) agonist | |||
| 0.043 | 0.018 | 0.043 | Retinoid X alpha receptor agonist | |||
| 0.03 | 0.004 | 0.03 | Nicotinic acid receptor 1 antagonist | |||
| 0.052 | 0.027 | 0.052 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.036 | 0.011 | 0.036 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.042 | 0.017 | 0.042 | Somatostatin 5 agonist | |||
| 0.092 | 0.067 | 0.092 | MAP kinase kinase 1 inhibitor | |||
| 0.048 | 0.024 | 0.048 | AICAR transformylase inhibitor | |||
| 0.053 | 0.028 | 0.053 | Endothelin-converting enzyme inhibitor | |||
| 0.055 | 0.03 | 0.055 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.058 | 0.034 | 0.058 | Leukotriene C antagonist | |||
| 0.056 | 0.032 | 0.056 | Autotaxin inhibitor | |||
| 0.085 | 0.062 | 0.085 | Interleukin 5 antagonist | |||
| 0.234 | 0.211 | 0.234 | MAP kinase kinase 6 inhibitor | |||
| 0.047 | 0.024 | 0.047 | Beta adrenoreceptor agonist | |||
| 0.039 | 0.016 | 0.039 | Retinoid X alpha receptor antagonist | |||
| 0.13 | 0.108 | 0.13 | MAP kinase 3 inhibitor | |||
| 0.031 | 0.009 | 0.031 | Cholecystokinin agonist | |||
| 0.073 | 0.052 | 0.073 | CDC25A inhibitor | |||
| 0.026 | 0.005 | 0.026 | Follicle-stimulating hormone antagonist | |||
| 0.039 | 0.018 | 0.039 | Glutamate (mGluR8) antagonist | |||
| 0.15 | 0.13 | 0.15 | EphB2 antagonist | |||
| 0.031 | 0.011 | 0.031 | Integrin alpha2beta1 antagonist | |||
| 0.038 | 0.018 | 0.038 | Angiotensin II receptor antagonist | |||
| 0.036 | 0.016 | 0.036 | Protein kinase C beta II inhibitor | 0.032 0.022 CID_53481645 | ||
| 0.029 | 0.009 | 0.029 | Somatostatin 3 antagonist | |||
| 0.097 | 0.078 | 0.097 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.03 | 0.011 | 0.03 | Somatostatin 4 antagonist | 0.027 0.014 CID_53481645 | ||
| 0.05 | 0.031 | 0.05 | Dopamine beta hydroxylase inhibitor | |||
| 0.116 | 0.097 | 0.187 | Protein kinase stimulant | 0.187 0.047 CID_53481645 | CID_53481645 | |
| 0.048 | 0.029 | 0.048 | Adenylate cyclase 1 inhibitor | |||
| 0.123 | 0.105 | 0.123 | Acetylcholine M1 receptor antagonist | |||
| 0.027 | 0.009 | 0.027 | ICAM 1 antagonist | |||
| 0.024 | 0.006 | 0.024 | Somatostatin 3 agonist | |||
| 0.032 | 0.014 | 0.032 | 5 Hydroxytryptamine 6 agonist | |||
| 0.03 | 0.012 | 0.03 | Thyroid hormone agonist | |||
| 0.042 | 0.024 | 0.042 | Urate transporter 1 inhibitor | |||
| 0.092 | 0.075 | 0.092 | Anabolic | |||
| 0.121 | 0.104 | 0.121 | Aurora-C kinase inhibitor | |||
| 0.036 | 0.02 | 0.036 | Glutamate (mGluR4) agonist | |||
| 0.063 | 0.047 | 0.063 | Neutrophil collagenase inhibitor | |||
| 0.133 | 0.117 | 0.133 | Antipruritic | |||
| 0.056 | 0.041 | 0.056 | Fatty acid synthase inhibitor | 0.052 0.048 CID_53481645 | ||
| 0.023 | 0.007 | 0.023 | Cholecystokinin A agonist | |||
| 0.057 | 0.042 | 0.057 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.034 | 0.019 | 0.034 | Glutamate (mGluR3) agonist | |||
| 0.055 | 0.04 | 0.055 | Beta 1 adrenoreceptor antagonist | |||
| 0.066 | 0.051 | 0.066 | Carbonic anhydrase VA inhibitor | |||
| 0.048 | 0.033 | 0.07 | Glucose-6-phosphate isomerase inhibitor | 0.07 0.012 CID_53481645 | CID_53481645 | |
| 0.041 | 0.026 | 0.041 | Dihydropteroate synthase inhibitor | |||
| 0.061 | 0.046 | 0.061 | Beta 2 adrenoreceptor agonist | |||
| 0.067 | 0.053 | 0.067 | HIV-1 integrase inhibitor | |||
| 0.102 | 0.088 | 0.102 | Histone deacetylase class III inhibitor | |||
| 0.063 | 0.049 | 0.063 | Beta adrenoreceptor antagonist | |||
| 0.071 | 0.057 | 0.071 | Carbonic anhydrase XIII inhibitor | |||
| 0.043 | 0.029 | 0.043 | Histamine H2 receptor agonist | |||
| 0.026 | 0.013 | 0.026 | Retinoid X gamma receptor agonist | |||
| 0.047 | 0.034 | 0.047 | Mineralocorticoid receptor antagonist | |||
| 0.064 | 0.051 | 0.064 | 5 Hydroxytryptamine agonist | |||
| 0.023 | 0.01 | 0.023 | Retinoic acid beta receptor agonist | |||
| 0.085 | 0.072 | 0.085 | Polo-like kinase-1 inhibitor | |||
| 0.06 | 0.047 | 0.06 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.024 | 0.012 | 0.024 | Retinoic acid gamma receptor agonist | |||
| 0.037 | 0.024 | 0.037 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.023 | 0.011 | 0.023 | Retinoic acid alpha receptor antagonist | |||
| 0.095 | 0.083 | 0.095 | Polo-like kinase-4 inhibitor | |||
| 0.031 | 0.019 | 0.031 | 5 Hydroxytryptamine 1D agonist | |||
| 0.117 | 0.105 | 0.117 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.062 | 0.05 | 0.097 | Neuraminidase (influenza) inhibitor | 0.097 0.017 CID_53481645 | CID_53481645 | |
| 0.027 | 0.015 | 0.027 | Thymidine phosphorylase inhibitor | |||
| 0.022 | 0.01 | 0.022 | Retinoic acid receptor antagonist | |||
| 0.039 | 0.028 | 0.039 | Membrane dipeptidase inhibitor | |||
| 0.016 | 0.005 | 0.016 | Egl nine homolog 3 inhibitor | |||
| 0.099 | 0.087 | 0.195 | Topoisomerase II inhibitor | 0.195 0.034 CID_53481645 | CID_53481645 | |
| 0.059 | 0.048 | 0.059 | Glucagon-like peptide 1 agonist | |||
| 0.02 | 0.009 | 0.02 | Kainate receptor 3 antagonist | |||
| 0.026 | 0.015 | 0.026 | Glutamate (mGluR1) agonist | |||
| 0.029 | 0.019 | 0.029 | Endothelin receptor antagonist | |||
| 0.029 | 0.019 | 0.029 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.035 | 0.025 | 0.035 | Retinoid X receptor agonist | |||
| 0.092 | 0.082 | 0.092 | Folate antagonist | |||
| 0.024 | 0.015 | 0.024 | Retinoic acid receptor agonist | |||
| 0.023 | 0.014 | 0.023 | Beta 1 adrenoreceptor agonist | |||
| 0.022 | 0.013 | 0.022 | Retinoid X beta receptor agonist | |||
| 0.049 | 0.04 | 0.049 | Prostaglandin antagonist | |||
| 0.054 | 0.046 | 0.054 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.015 | 0.007 | 0.015 | Integrin beta2 antagonist | |||
| 0.112 | 0.103 | 0.112 | Protein kinase C nu inhibitor | |||
| 0.114 | 0.106 | 0.114 | Nav1.6 sodium channel blocker | |||
| 0.029 | 0.021 | 0.029 | AMPA 2 receptor antagonist | |||
| 0.058 | 0.051 | 0.058 | DNA gyrase inhibitor | |||
| 0.109 | 0.101 | 0.109 | Alkaline phosphatase inhibitor | |||
| 0.237 | 0.229 | 0.647 | Apoptosis agonist | 0.647 0.04 CID_53481645 | CID_53481645 | |
| 0.047 | 0.04 | 0.047 | Beta 2 adrenoreceptor antagonist | |||
| 0.013 | 0.006 | 0.013 | Thrombopoietin agonist | |||
| 0.042 | 0.036 | 0.042 | Histamine H1 receptor agonist | |||
| 0.096 | 0.09 | 0.096 | CDC-like kinase 3 inhibitor | |||
| 0.108 | 0.102 | 0.176 | DNA repair enzyme inhibitor | 0.176 0.015 CID_53481645 | CID_53481645 | |
| 0.042 | 0.036 | 0.042 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.02 | 0.015 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.013 | 0.007 | 0.013 | Retinoic acid beta receptor antagonist | |||
| 0.037 | 0.032 | 0.037 | Leukotriene C4 antagonist | |||
| 0.034 | 0.029 | 0.034 | Histone deacetylase 7 inhibitor | |||
| 0.097 | 0.092 | 0.097 | Cholesterol synthesis inhibitor | |||
| 0.177 | 0.173 | 0.177 | Transcription factor STAT inhibitor | |||
| 0.021 | 0.017 | 0.021 | Glutamate (mGluR1a) agonist | |||
| 0.025 | 0.02 | 0.025 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.183 | 0.179 | 0.183 | MAP kinase kinase 3 inhibitor | |||
| 0.037 | 0.032 | 0.037 | Histone deacetylase 9 inhibitor | |||
| 0.012 | 0.008 | 0.012 | Retinoic acid receptor gamma antagonist | |||
| 0.02 | 0.016 | 0.02 | Neuraminidase (Influenza B) inhibitor | |||
| 0.125 | 0.121 | 0.125 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.059 | 0.055 | 0.059 | Carbonic anhydrase V inhibitor | |||
| 0.026 | 0.023 | 0.026 | Retinoid X gamma receptor antagonist | |||
| 0.037 | 0.034 | 0.037 | Liver X receptor alpha agonist | |||
| 0.077 | 0.074 | 0.077 | Factor XII inhibitor | |||
| 0.014 | 0.011 | 0.014 | Egl nine homolog 1 inhibitor | |||
| 0.053 | 0.051 | 0.053 | Androgen agonist | |||
| 0.056 | 0.054 | 0.056 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.034 | 0.033 | 0.034 | DNA gyrase subunit B inhibitor | |||
| 0.012 | 0.01 | 0.012 | Carbonic anhydrase XI inhibitor | |||
| 0.036 | 0.035 | 0.036 | Factor XIa inhibitor | |||
| 0.022 | 0.021 | 0.022 | Prostaglandin H2 antagonist | |||
| 0.086 | 0.087 | 0.233 | Expectorant | 0.233 0.015 CID_53481645 | CID_53481645 | |
| 0.136 | 0.138 | 0.302 | Non-steroidal antiinflammatory agent | 0.302 0.028 CID_53481645 | CID_53481645 | |
| 0.039 | 0.042 | 0.081 | Mannosidase inhibitor | 0.081 0.008 CID_53481645 | CID_53481645 | |
| 0.033 | 0.038 | 0.039 | Toll-Like receptor 2 agonist | 0.039 0.03 CID_53481645 | CID_53481645 | |
| 0.051 | 0.059 | 0.363 | Selectin antagonist | 0.363 0.004 CID_53481645 | CID_53481645 | |
| 0.058 | 0.067 | 0.068 | Protein kinase C alpha inhibitor | 0.068 0.047 CID_53481645 | CID_53481645 | |
| 0.192 | 0.205 | 0.492 | Immunosuppressant | 0.492 0.035 CID_53481645 | CID_53481645 | |
| 0.006 | 0.025 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.007 CID_53481645 | CID_53481645 | |
| 0.042 | 0.063 | 0.082 | Alpha-mannosidase inhibitor | 0.082 0.01 CID_53481645 | CID_53481645 | |
| 0.04 | 0.067 | 0.087 | Glucose-6-phosphate translocase inhibitor | 0.087 0.009 CID_53481645 | CID_53481645 | |
| 0.084 | 0.111 | 0.201 | Alkylator | 0.201 0.026 CID_53481645 | CID_53481645 | |
| 0.052 | 0.082 | 0.1 | Na+ K+ transporting ATPase inhibitor | 0.1 0.032 CID_53481645 | CID_53481645 | |
| 0.058 | 0.095 | 0.129 | Protein kinase A inhibitor | 0.129 0.03 CID_53481645 | CID_53481645 | |
| 0.104 | 0.143 | 0.282 | Insulin secretagoues | 0.282 0.015 CID_53481645 | CID_53481645 | |
| 0.108 | 0.147 | 0.164 | Amyloid beta aggregation inhibitor | 0.164 0.099 CID_53481645 | CID_53481645 | |
| 0.036 | 0.078 | 0.086 | Factor IXa inhibitor | 0.086 0.014 CID_53481645 | CID_53481645 | |
| 0.116 | 0.16 | 0.49 | Hepatoprotectant | 0.49 0.007 CID_53481645 | CID_53481645 | |
| 0.137 | 0.182 | 0.612 | Antioxidant | 0.612 0.01 CID_53481645 | CID_53481645 | |
| 0.135 | 0.18 | 0.293 | Spasmolytic | 0.293 0.073 CID_53481645 | CID_53481645 | |
| 0.011 | 0.068 | 0.024 | Antibiotic Anthracycline-like | 0.024 0.005 CID_53481645 | CID_53481645 | |
| 0.06 | 0.12 | 0.269 | Topoisomerase I inhibitor | 0.269 0.014 CID_53481645 | CID_53481645 | |
| 0.074 | 0.136 | 0.182 | Beta amyloid protein antagonist | 0.182 0.023 CID_53481645 | CID_53481645 | |
| 0.057 | 0.13 | 0.123 | Protein kinase C mu inhibitor | 0.123 0.04 CID_53481645 | CID_53481645 | |
| 0.013 | 0.092 | 0.059 | Sodium/glucose cotransporter inhibitor | 0.059 0.004 CID_53481645 | CID_53481645 | |
| 0.141 | 0.223 | 0.365 | Peptidyltransferase inhibitor | 0.365 0.01 CID_53481645 | CID_53481645 | |
| 0.01 | 0.092 | 0.057 | Sodium/glucose cotransporter 2 inhibitor | 0.057 0.005 CID_53481645 | CID_53481645 | |
| 0.063 | 0.153 | 0.18 | DNA polymerase I inhibitor | 0.18 0.035 CID_53481645 | CID_53481645 | |
| 0.162 | 0.257 | 0.232 | Antiobesity | 0.232 0.175 CID_53481645 | CID_53481645 | |
| 0.039 | 0.144 | 0.096 | Histone deacetylase SIRT1 stimulant | 0.096 0.03 CID_53481645 | CID_53481645 | |
| 0.039 | 0.144 | 0.096 | Histone deacetylase stimulant | 0.096 0.03 CID_53481645 | CID_53481645 | |
| 0.209 | 0.32 | 0.785 | Antiinflammatory | 0.785 0.018 CID_53481645 | CID_53481645 | |
| 0.018 | 0.133 | 0.055 | Aldose reductase inhibitor | 0.055 0.035 CID_53481645 | CID_53481645 | |
| 0.052 | 0.168 | 0.127 | DNA intercalator | 0.127 0.054 CID_53481645 | CID_53481645 | |
| 0.065 | 0.186 | 0.309 | Lipid peroxidase inhibitor | 0.309 0.018 CID_53481645 | CID_53481645 | |
| 0.089 | 0.209 | 0.444 | Nitric oxide antagonist | 0.444 0.021 CID_53481645 | CID_53481645 | |
| 0.035 | 0.157 | 0.127 | Topoisomerase II alpha inhibitor | 0.127 0.028 CID_53481645 | CID_53481645 | |
| 0.016 | 0.138 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.007 CID_53481645 | CID_53481645 | |
| 0.04 | 0.172 | 0.062 | Lipocortins synthesis agonist | 0.062 0.031 CID_53481645 | CID_53481645 | |
| 0.054 | 0.19 | 0.178 | Transcription factor NF kappa B stimulant | 0.178 0.011 CID_53481645 | CID_53481645 | |
| 0.053 | 0.19 | 0.093 | Thioredoxin inhibitor | 0.093 0.058 CID_53481645 | CID_53481645 | |
| 0.022 | 0.161 | 0.177 | Antineoplastic antibiotic | 0.177 0.025 CID_53481645 | CID_53481645 | |
| 0.025 | 0.167 | 0.048 | Cytokine production stimulant | 0.048 0.035 CID_53481645 | CID_53481645 | |
| 0.093 | 0.235 | 0.289 | Platelet antagonist | 0.289 0.056 CID_53481645 | CID_53481645 | |
| 0.129 | 0.272 | 0.329 | Angiogenesis inhibitor | 0.329 0.08 CID_53481645 | CID_53481645 | |
| 0.111 | 0.256 | 0.533 | Hypoglycemic | 0.533 0.013 CID_53481645 | CID_53481645 | |
| 0.053 | 0.212 | 0.113 | Multidrug resistance-associated protein 1 inhibitor | 0.113 0.057 CID_53481645 | CID_53481645 | |
| 0.126 | 0.288 | 0.502 | Immunomodulator | 0.502 0.023 CID_53481645 | CID_53481645 | |
| 0.006 | 0.173 | 0.019 | Corticosteroid-like | 0.019 0.018 CID_53481645 | CID_53481645 | |
| 0.137 | 0.316 | 0.384 | Caspase 3 stimulant | 0.384 0.049 CID_53481645 | CID_53481645 | |
| 0.069 | 0.286 | 0.464 | Platelet adhesion inhibitor | 0.464 0.007 CID_53481645 | CID_53481645 | |
| 0.049 | 0.267 | 0.171 | Toll-Like receptor 4 antagonist | 0.171 0.012 CID_53481645 | CID_53481645 | |
| 0.016 | 0.235 | 0.097 | Protein 50S ribosomal subunit inhibitor | 0.097 0.014 CID_53481645 | CID_53481645 | |
| 0.054 | 0.273 | 0.191 | Cell adhesion inhibitor | 0.191 0.027 CID_53481645 | CID_53481645 | |
| 0.053 | 0.281 | 0.232 | Anticoagulant | 0.232 0.043 CID_53481645 | CID_53481645 | |
| 0.015 | 0.249 | 0.055 | Microtubule stabilization | 0.055 0.021 CID_53481645 | CID_53481645 | |
| 0.037 | 0.276 | 0.106 | Cell adhesion molecule inhibitor | 0.106 0.03 CID_53481645 | CID_53481645 | |
| 0.031 | 0.287 | 0.101 | ATPase (Vacuolar H+) inhibitor | 0.101 0.038 CID_53481645 | CID_53481645 | |
| 0.017 | 0.308 | 0.062 | Nitric oxide donor | 0.062 0.045 CID_53481645 | CID_53481645 | |
| 0.058 | 0.356 | 0.132 | Interleukin 6 antagonist | 0.132 0.121 CID_53481645 | CID_53481645 | |
| 0.061 | 0.364 | 0.393 | Vasodilator | 0.393 0.024 CID_53481645 | CID_53481645 | |
| 0.052 | 0.368 | 0.147 | P-glycoprotein inhibitor | 0.147 0.122 CID_53481645 | CID_53481645 | |
| 0.047 | 0.363 | 0.203 | Hypolipemic | 0.203 0.091 CID_53481645 | CID_53481645 | |
| 0.013 | 0.431 | 0.067 | Antibiotic Aminoglycoside-like | 0.067 0.006 CID_53481645 | CID_53481645 | |
| 0.005 | 0.48 | 0.04 | Protein 30S ribosomal subunit inhibitor | 0.04 0.01 CID_53481645 | CID_53481645 | |
| 0.028 | 0.581 | 0.412 | Tumour necrosis factor alpha release inhibitor | 0.412 0.025 CID_53481645 | CID_53481645 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |